-
公开(公告)号：US20230137646A1
公开(公告)日：2023-05-04
申请号：US17969824
申请日：2022-10-20
发明人： Jay Neitz , Maureen Neitz
摘要： Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.
-
公开(公告)号：US11493781B2
公开(公告)日：2022-11-08
申请号：US17352570
申请日：2021-06-21
发明人： Jay Neitz , Maureen Neitz
摘要： Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.
-
公开(公告)号：US20240295752A1
公开(公告)日：2024-09-05
申请号：US18403026
申请日：2024-01-03
发明人： Jay Neitz , Maureen Neitz
CPC分类号： G02C7/04 , A61K9/0048 , G02C7/02 , G02C7/061 , G02C7/10 , G02C7/16 , A61B3/1005 , A61B5/107 , G02C2202/24
摘要： Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.
-
公开(公告)号：US11815745B2
公开(公告)日：2023-11-14
申请号：US17969824
申请日：2022-10-20
发明人： Jay Neitz , Maureen Neitz
CPC分类号： G02C7/04 , A61K9/0048 , G02C7/02 , G02C7/061 , G02C7/10 , G02C7/16 , A61B3/1005 , A61B5/107 , G02C2202/24
摘要： Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.
-
公开(公告)号：US11048102B2
公开(公告)日：2021-06-29
申请号：US17008167
申请日：2020-08-31
发明人： Jay Neitz , Maureen Neitz
摘要： Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.
-
公开(公告)号：US11899288B2
公开(公告)日：2024-02-13
申请号：US18341661
申请日：2023-06-26
发明人： Jay Neitz , Maureen Neitz
CPC分类号： G02C7/04 , A61K9/0048 , G02C7/02 , G02C7/061 , G02C7/10 , G02C7/16 , A61B3/1005 , A61B5/107 , G02C2202/24
摘要： Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.
-
公开(公告)号：US20230384618A1
公开(公告)日：2023-11-30
申请号：US18341661
申请日：2023-06-26
发明人： Jay Neitz , Maureen Neitz
CPC分类号： G02C7/04 , G02C7/02 , A61K9/0048 , G02C7/061 , G02C7/10 , G02C7/16 , A61B3/1005
摘要： Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.
-
公开(公告)号：US20210341753A1
公开(公告)日：2021-11-04
申请号：US17352570
申请日：2021-06-21
发明人： Jay Neitz , Maureen Neitz
摘要： Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.019 秒)
